Donald Notman, Chief Financial Officer at OCULAR THERAPEUTIX, INC (OCUL), bought 4,800 shares at $4.00 ($19K) on 2017-12-07, disclosed to the SEC on 2017-12-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| OCUL | SELL | 2026-02-04 | $101K | — | Filing → |
| OCUL | SELL | 2025-09-04 | $13K | — | Filing → |
| OCUL | SELL | 2025-02-04 | $223K | — | Filing → |